Results 151 to 160 of about 10,836 (202)

β-Adrenergic Receptors: Not Always Outside-In. [PDF]

Physiology (Bethesda)
Dodge-Kafka KL, Turcotte MG, Possidento SM, Kapiloff MS.   +3 more
europepmc   +1 more source

Prognostic Impact of Concomitant Beta-Blocker Use on Survival in EGFR-Mutant Metastatic Non-Small Cell Lung Cancer Patients Treated with Erlotinib. [PDF]

Medicina (Kaunas)
Yıldız O, Aykut T, Kaya BE, Genç Ö, Gürbüz AF, Saçkan F, Eryılmaz MK, Koçak MZ, Araz M, Artaç M.   +9 more
europepmc   +1 more source

Biased Orthosteric Agonism and Allosteric Modulation: Emerging Strategies for Developing New Class of β-Agonists for Obstructive Airway Diseases. [PDF]

Am J Respir Cell Mol Biol
Shah SD, Deshpande DA.
europepmc   +1 more source

MAPK, PI3K/Akt Pathways, and GSK-3β Activity in Severe Acute Heart Failure in Intensive Care Patients: An Updated Review. [PDF]

J Cardiovasc Dev Dis
Meco M, Giustiniano E, Nisi F, Zulli P, Agosteo E.   +4 more
europepmc   +1 more source

The Differential Involvement of α1-Adrenoceptor Subtypes in the Molecular Effects of Antidepressant Drugs. [PDF]

Int J Mol Sci
Nalepa I, Chorązka K, Kreiner G, Zelek-Molik A, Haduch A, Daniel WA, Chmielarz P, Maziarz K, Kuśmierczyk J, Wilczkowski M, Bielawski A, Kowalska M.   +11 more
europepmc   +1 more source

Advancements in Beta-Adrenergic Therapy and Novel Personalised Approach for Portal Hypertension: A Narrative Review. [PDF]

Life (Basel)
Avram RI, Minea HO, Huiban L, Damian IR, Muset MC, Juncu S, Muzica CM, Zenovia S, Singeap AM, Girleanu I, Stanciu C, Trifan A.   +11 more
europepmc   +1 more source

Non-receptor tyrosine kinase signaling pathways and therapeutic implications. [PDF]

Signal Transduct Target Ther
Hossain MDA, Marques Cuoco C, Sodaye SH, Beci J, Belkas K.   +4 more
europepmc   +1 more source

The role of dopamine in the life history of bivalves: a review. [PDF]

Front Zool
Nikishchenko V, Dyachuk V.
europepmc   +1 more source

Isoprenaline shows unique kinase dependencies in stimulating β₁AR-β-arrestin2 interaction compared to endogenous catecholamines. [PDF]

Mol Pharmacol
Matthees ESF, Kletzin LE, Löbbert A, Hoffmann JS, Große C, Gossert AD, Hoffmann C.   +6 more
europepmc   +1 more source

In-silico target prediction and pathway analysis of propranolol as a potential therapeutic agent for hepatocellular carcinoma. [PDF]

PLoS One
Ahmad I, Khan SA, Abu Bakar M, Shakoor A, Zia AW.   +4 more
europepmc   +1 more source